Another matchless patient welfare and treatment program initiated to treat the Blood Cancer (CML) cases. A MoU between GoAJK and M/s Novartis Pharma (Pakistan) Limited, Pakistan has been signed on 22 March 2017 for provision of free treatment to blood cancers (CML) patients of AJ&K.
Treatment CML cases is very expensive.Cost dependent upon the type of medicine used. It ranges from Rs 1.5-4.5 million rupees per patient (annually). The MOU defines that 90% cost will bear Novartis Pakistan and 10 %, the subsidized rate will bear Government. Currently there are 131 patient registered and under treatment